Voyager Therapeutics, Inc. Operating Cash Flow
Voyager Therapeutics, Inc. (VYGR) reported Operating Cash Flow of -$59.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Voyager Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$25.84M.
- Voyager Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$33.42M.
- Voyager Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$30.26M.
- Voyager Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$31.05M.
- Voyager Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$132.47M.
- Voyager Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$15.31M, a 119.65% decline from fiscal 2023.
- Voyager Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $77.92M.
- Voyager Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$12.51M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$25.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$59.26M 10-Q · filed 2026-08-06 | -$89.52M derived: sum of 3 quarters · filed 2026-08-06 | -$120.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$33.42M 10-Q · filed 2026-05-07 | -$63.68M derived: sum of 2 quarters · filed 2026-05-07 | -$94.73M derived: sum of 3 quarters · filed 2026-05-07 | -$127.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$30.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$61.31M derived: sum of 2 quarters · filed 2026-03-09 | -$94.57M derived: sum of 3 quarters · filed 2026-08-06 | -$132.47M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$31.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$64.31M derived: sum of 2 quarters · filed 2026-08-06 | -$102.20M 10-Q · filed 2025-11-10 | -$116.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$33.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$71.16M 10-Q · filed 2026-08-06 | -$85.69M derived: sum of 3 quarters · filed 2026-08-06 | -$113.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$37.90M 10-Q · filed 2026-05-07 | -$52.42M derived: sum of 2 quarters · filed 2026-05-07 | -$80.39M derived: sum of 3 quarters · filed 2026-05-07 | -$111.97M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$14.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$42.50M derived: sum of 2 quarters · filed 2026-03-09 | -$74.08M derived: sum of 3 quarters · filed 2026-03-09 | -$15.31M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$27.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$59.55M derived: sum of 2 quarters · filed 2025-11-10 | -$781.00K 10-Q · filed 2025-11-10 | -$24.54M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | -$31.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $27.19M 10-Q · filed 2025-08-06 | $3.43M derived: sum of 3 quarters · filed 2026-03-09 | -$17.62M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $58.77M 10-Q · filed 2025-05-06 | $35.01M derived: sum of 2 quarters · filed 2026-03-09 | $13.96M derived: sum of 3 quarters · filed 2026-03-09 | $13.12M derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | -$23.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$44.81M derived: sum of 2 quarters · filed 2026-03-09 | -$45.65M derived: sum of 3 quarters · filed 2026-03-09 | $77.92M 10-K · filed 2026-03-09 |
| 2023-09-30 | -$21.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$21.89M derived: sum of 2 quarters · filed 2024-11-12 | $101.68M 10-Q · filed 2024-11-12 | $89.44M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | -$835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $122.73M 10-Q · filed 2024-08-06 | $110.49M derived: sum of 3 quarters · filed 2025-03-11 | $94.28M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $123.56M 10-Q · filed 2024-05-13 | $111.32M derived: sum of 2 quarters · filed 2025-03-11 | $95.11M derived: sum of 3 quarters · filed 2025-03-11 | $76.63M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | -$12.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$28.45M derived: sum of 2 quarters · filed 2025-03-11 | -$46.94M derived: sum of 3 quarters · filed 2025-03-11 | -$12.51M 10-K · filed 2025-03-11 |
| 2022-09-30 | -$16.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$34.69M derived: sum of 2 quarters · filed 2023-11-06 | -$265.00K 10-Q · filed 2023-11-06 | $10.93M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$18.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $15.94M 10-Q · filed 2023-08-03 | $27.14M derived: sum of 3 quarters · filed 2024-02-28 | $6.43M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $34.43M 10-Q · filed 2023-05-09 | $45.62M derived: sum of 2 quarters · filed 2024-02-28 | $24.91M derived: sum of 3 quarters · filed 2024-02-28 | $2.19M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$9.51M derived: sum of 2 quarters · filed 2024-02-28 | -$32.23M derived: sum of 3 quarters · filed 2024-02-28 | -$53.52M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$20.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$43.43M derived: sum of 2 quarters · filed 2022-11-08 | -$64.72M 10-Q · filed 2022-11-08 | -$86.70M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | -$22.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$44.01M 10-Q · filed 2022-08-04 | -$65.99M derived: sum of 3 quarters · filed 2023-03-07 | -$90.73M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | -$21.29M 10-Q · filed 2022-05-04 | -$43.27M derived: sum of 2 quarters · filed 2023-03-07 | -$68.01M derived: sum of 3 quarters · filed 2023-03-07 | -$89.21M derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | -$21.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$46.72M derived: sum of 2 quarters · filed 2023-03-07 | -$67.92M derived: sum of 3 quarters · filed 2023-03-07 | -$96.72M 10-K · filed 2023-03-07 |
| 2020-09-30 | -$24.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$45.94M derived: sum of 2 quarters · filed 2021-11-02 | -$74.74M 10-Q · filed 2021-11-02 | -$98.10M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | -$21.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$50.00M 10-Q · filed 2021-08-09 | -$73.36M derived: sum of 3 quarters · filed 2022-03-08 | -$94.94M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | -$28.80M 10-Q · filed 2021-05-10 | -$52.16M derived: sum of 2 quarters · filed 2022-03-08 | -$73.74M derived: sum of 3 quarters · filed 2022-03-08 | -$105.29M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | -$23.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$44.94M derived: sum of 2 quarters · filed 2022-03-08 | -$76.50M derived: sum of 3 quarters · filed 2022-03-08 | $48.67M 10-K · filed 2022-03-08 |
| 2019-09-30 | -$21.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$53.14M derived: sum of 2 quarters · filed 2020-11-09 | $72.03M 10-Q · filed 2020-11-09 | $47.68M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$31.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $93.61M 10-Q · filed 2020-08-10 | $69.26M derived: sum of 3 quarters · filed 2021-02-25 | $51.61M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $125.16M 10-Q · filed 2020-05-06 | $100.81M derived: sum of 2 quarters · filed 2021-02-25 | $83.17M derived: sum of 3 quarters · filed 2021-02-25 | $60.66M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$24.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$41.99M derived: sum of 2 quarters · filed 2021-02-25 | -$64.50M derived: sum of 3 quarters · filed 2021-02-25 | -$15.89M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$17.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$40.15M derived: sum of 2 quarters · filed 2019-11-06 | $8.46M 10-Q · filed 2019-11-06 | -$6.37M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | -$22.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $26.11M 10-Q · filed 2019-08-09 | $11.27M derived: sum of 3 quarters · filed 2020-03-03 | -$4.61M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $48.61M 10-Q · filed 2019-05-07 | $33.78M derived: sum of 2 quarters · filed 2020-03-03 | $17.89M derived: sum of 3 quarters · filed 2020-03-03 | $1.55M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | -$14.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$30.72M derived: sum of 2 quarters · filed 2020-03-03 | -$47.06M derived: sum of 3 quarters · filed 2020-03-03 | -$61.35M 10-K · filed 2020-03-03 |
| 2017-09-30 | -$15.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$32.22M derived: sum of 2 quarters · filed 2018-11-07 | -$46.52M 10-Q · filed 2018-11-07 | -$59.61M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$16.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$30.63M 10-Q · filed 2018-08-07 | -$43.72M derived: sum of 3 quarters · filed 2019-02-26 | -$53.91M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$14.29M 10-Q · filed 2018-05-10 | -$27.39M derived: sum of 2 quarters · filed 2019-02-26 | -$37.58M derived: sum of 3 quarters · filed 2019-02-26 | |
| 2016-12-31 | -$13.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$23.28M derived: sum of 2 quarters · filed 2019-02-26 | -$42.48M 10-K · filed 2019-02-26 | |
| 2016-09-30 | -$10.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$29.39M 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | -$19.20M 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | $41.30M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |